0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint | Scientific Discovery and the Future of Medicine

Optogenetics and the Circuit Dynamics of Psychiatric Disease

Karl Deisseroth, MD, PhD1,2,3; Amit Etkin, MD, PhD1; Robert C. Malenka, MD, PhD1
[+] Author Affiliations
1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California
2Department of Bioengineering, Stanford University, Stanford, California
3Howard Hughes Medical Institute, Stanford University, Stanford, California
JAMA. 2015;313(20):2019-2020. doi:10.1001/jama.2015.2544.
Text Size: A A A
Published online

Extract

This Viewpoint discusses the key breakthroughs, reviews some of the resulting insights into pathophysiology of psychiatry-related symptoms, and illustrates the implications of this emerging vision for circuit-guided psychiatry.

Optogenetics is a method for delivering millisecond-precision control (for activation or inhibition) to targeted cells using light within freely behaving mammals.1 The components of this method, as practiced today, involve (1) lasers and fiber optics for light delivery into the nervous system and (2) genes called microbial opsins, which encode light-activated proteins that regulate transmembrane ion conductance (Figure). Microbial opsins display diverse color sensitivity and conductance properties, with diversity generated by mutagenesis or arising naturally in the biosphere. Constituted by single genes, these microbial opsins can be targeted using a toolbox of genetic techniques, thereby specifying light-induced current flow in cells defined by function (eg, with excitatory, inhibitory, or dopaminergic properties) and anatomy (eg, with cell bodies in one location and projections going to another specific location across the brain). Light guidance with versatile fiber optics or spatial light modulators allows further resolution. Rapid advances in materials and electrical engineering have enabled opsin activation in neural tissue wirelessly using tiny LEDs.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure.
Steps in Optogenetic Research

Diverse opsin genes from microbes are engineered in the laboratory to allow light-activated regulation of ion flow and biochemical pathways. Targeted opsins allow cell-specific control with light with precision not achievable by electrodes. Mice can be implanted with fiberoptics that can both deliver optogenetic control and collect fluorescent readout of neural activity with fiber photometry. At left, black trace shows neuronal membrane voltage; blue ticks show pulses of light driving ChR2 to elicit action potentials (spikes in the membrane voltage); and yellow bar shows steady light providing inhibition of the neuron through NpHR. At right, red ticks indicate rewarding sucrose solution ingestion; black trace shows corresponding elevations in deep brain dopamine neuron activity.2

Graphic Jump Location

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

6,468 Views
5 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Multimedia

Author Reading

audio player

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Care at the Close of Life: Evidence and Experience
Psychological Disorders Contributing to Fatigue

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Is This Patient Clinically Depressed?

brightcove.createExperiences();